Zivo Bioscience- Warrants (29/04/2026) Long Term Debt

As of the most recent data (June 2026), ZIVOW shows a long-term debt of $19K. That compares with $280K in the prior-year period — down 93.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ZIVOW's long-term debt is now $19K (was $280K) — a 93.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Zivo Bioscience- Warrants (29/04/2026) is outperforming or lagging.

Tracking ZIVOW's long-term debt over time shows whether Zivo Bioscience- Warrants (29/04/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $19K That compares with $280K in the prior-year period — down 93.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Zivo Bioscience- Warrants (29/04/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $19K) with ownership activity and broader fundamentals.

Zivo Bioscience- Warrants (29/04/2026)'s long-term debt is $19K; compare it with other Consumer Discretionary names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.